Topic · page 104 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 4,121–4,160 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

Diabetologia13 May 2023
Age at diagnosis modifies associations of type 2 diabetes with cancer incidence and mortality: a retrospective matched-cohort study
Cohort study
Diabetologia12 May 2023
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis
Research article
Diabet Med12 May 2023
Cost‐effectiveness analysis of once‐daily insulin glargine 300 U/mL versus insulin degludec 100 U/mL using the BRAVO diabetes model
Research article
Diabetes Obes Metab11 May 2023
Long‐acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population‐based cohort study
Cohort study
Diabetes Obes Metab10 May 2023
The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials
Secondary analysis
J Diabetes Sci Technol10 May 2023
Dietary Self-Management Using Mobile Health Technology for Adults With Type 2 Diabetes: A Scoping Review
Research article
J Diabetes Sci Technol10 May 2023
Mobile Applications to Support Diabetes Self-Management Education: Patient Experiences and Provider Perspectives
Cross-sectional study
Diabetes Res Clin Pract10 May 2023
Efficacy of two doses of external counterpulsation (ECP) on glycemic control in people with type 2 diabetes mellitus: A randomized SHAM-controlled trial
Randomized controlled trial
Cardiovasc Diabetol9 May 2023
Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study
Cohort study
Ann Intern Med9 May 2023
Primary Occurrence of Cardiovascular Events After Adding Sodium–Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes
Cohort study
Cardiovasc Diabetol8 May 2023
An analysis of DPV and DIVE registry patients with chronic kidney disease according to the finerenone phase III clinical trial selection criteria
Cross-sectional study
Diabetes Res Clin Pract8 May 2023
The effectiveness of COVID–19 vaccination against all–cause mortality in patients with type 2 diabetes mellitus: The observation during the initial period of the cancellation of the “Dynamic Zero Policy” in mainland China
Cohort study
Obesity (Silver Spring)8 May 2023
Association between the month of starting a weight management program and weight change in people at high risk of type 2 diabetes: A prospective cohort study
Cohort study
Diabetes Obes Metab8 May 2023
Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: A sub‐analysis of the DIVERSITY‐CVR study
Secondary analysis
Diabetes Obes Metab8 May 2023
Incidence and predictors of remission and relapse of type 2 diabetes mellitus in Japan: Analysis of a nationwide patient registry (JDDM73)
Cohort study
Diabetes Technol Ther8 May 2023
Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTE
Secondary analysis
Diabet Med8 May 2023
Interventions to enhance pre‐pregnancy care for women with type 2 diabetes: A systematic review of the literature
Meta-analysis
Diabetes Obes Metab8 May 2023
Use of hospital care among Dutch diabetes patients
Cohort study
J Clin Endocrinol Metab7 May 2023
Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS
Secondary analysis
Diabetes Res Clin Pract7 May 2023
Diabetes mellitus with mild or moderate kidney dysfunction is associated with poor prognosis in patients with coronary artery disease: A large-scale cohort study
Cohort study
Diabetes Res Clin Pract6 May 2023
Prevalence of anemia and associated All-Cause mortality among adults with Diabetes: The role of chronic kidney disease
Cohort study
Diabetes Res Clin Pract6 May 2023
Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus
Cohort study
Int J Obes (Lond)6 May 2023
Eating behavior dimensions and 9-year weight loss maintenance: a sub-study of the Finnish Diabetes prevention study
Secondary analysis
Diabetologia6 May 2023
The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes
Meta-analysis
Lancet5 May 2023
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
Randomized controlled trial
Diabetes Care5 May 2023
Potential Value of Identifying Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Comparison of Novel Data-Driven Clustering With Risk-Driven Subgroups
Cohort study
Cardiovasc Diabetol5 May 2023
Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
Case-control study
Diabetes Care4 May 2023
Is COVID-19 to Blame? Trends of Incidence and Sex Ratio in Youth-Onset Type 2 Diabetes in Germany
Cohort study
Cardiovasc Diabetol4 May 2023
Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo—The Maastricht Study
Cross-sectional study
Cardiovasc Diabetol4 May 2023
Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
Cohort study
J Clin Endocrinol Metab4 May 2023
Dysmetabolism-related Early Sensory Deficits and Their Relationship With Peripheral Neuropathy Development
Cohort study
J Clin Endocrinol Metab4 May 2023
Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies
Cohort study
Diabet Med4 May 2023
Sex comparisons in the association of prediabetes and type 2 diabetes with cognitive function, depression, and quality of life: The Maastricht study
Cross-sectional study
Lancet Diabetes Endocrinol3 May 2023
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
Randomized controlled trial
BMJ Open Diabetes Res Care3 May 2023
Study design and baseline profile for adults with type 2 diabetes in the once-weekly subcutaneous SEmaglutide randomized PRAgmatic (SEPRA) trial
Randomized controlled trial
Diabetes Obes Metab3 May 2023
Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi‐heart study
Randomized controlled trial
Diabetes Obes Metab3 May 2023
iGlarLixi provides a higher derived time‐in‐range versus insulin glargine 100 U / mL or lixisenatide in Asian Pacific people with type 2 diabetes: A post hoc analysis
Secondary analysis
Diabetes Obes Metab3 May 2023
Longitudinal study investigating serum metabolites and their association with type 2 diabetes risk in a Korean population
Cohort study
Diabetes Care2 May 2023
Severe Mental Illness and Type 2 Diabetes Outcomes and Complications: A Nationwide Cohort Study
Cohort study
BMJ Open Diabetes Res Care2 May 2023
Variations in all-cause mortality, premature mortality and cause-specific mortality among persons with diabetes in Ontario, Canada
Cohort study

All 4,758 Briefs in ExploreShowing Briefs 4,121–4,160 of 4,758, newest first